Inhibition of IL-6 trans-signaling with soluble glycoprotein 130 (sgp130Fc) protein led to a significant reduction in atherosclerosis in Ldlr−/− mice, with reduced macrophage infiltration to the plaques [79]. The gene discussed is IL6; the disease is atherosclerosis.